These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 8555059)

  • 21. Murine IgG1 complexes trigger immune effector functions predominantly via Fc gamma RIII (CD16).
    Hazenbos WL; Heijnen IA; Meyer D; Hofhuis FM; Renardel de Lavalette CR; Schmidt RE; Capel PJ; van de Winkel JG; Gessner JE; van den Berg TK; Verbeek JS
    J Immunol; 1998 Sep; 161(6):3026-32. PubMed ID: 9743367
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Heterogeneity in the ability of IgG1 monoclonal anti-D to promote lymphocyte-mediated red cell lysis.
    Kumpel BM; Leader KA; Merry AH; Hadley AG; Poole GD; Blancher A; Goossens D; Hughes-Jones NC; Bradley BA
    Eur J Immunol; 1989 Dec; 19(12):2283-8. PubMed ID: 2481589
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Selection of a human anti-RhD monoclonal antibody for therapeutic use: impact of IgG glycosylation on activating and inhibitory Fc gamma R functions.
    Sibéril S; de Romeuf C; Bihoreau N; Fernandez N; Meterreau JL; Regenman A; Nony E; Gaucher C; Glacet A; Jorieux S; Klein P; Hogarth MP; Fridman WH; Bourel D; Béliard R; Teillaud JL
    Clin Immunol; 2006; 118(2-3):170-9. PubMed ID: 16332457
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Monocyte-bound monoclonal antibodies inhibit the Fc gamma RI-mediated phagocytosis of sensitized red cells: the efficiency and mechanism of inhibition are determined by the nature of the antigen.
    Shepard SL; Hadley AG
    Immunology; 1997 Feb; 90(2):314-22. PubMed ID: 9135563
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Agalactosyl glycoforms of IgG autoantibodies are pathogenic.
    Rademacher TW; Williams P; Dwek RA
    Proc Natl Acad Sci U S A; 1994 Jun; 91(13):6123-7. PubMed ID: 8016124
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunospecific red cell binding of iodine 125-labeled immunoglobulin G erythrocyte autoantibodies.
    Masouredis SP; Branks MJ; Garratty G; Victoria EJ
    J Lab Clin Med; 1987 Sep; 110(3):308-17. PubMed ID: 3611953
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of GnTIII in a recombinant anti-CD20 CHO production cell line: Expression of antibodies with altered glycoforms leads to an increase in ADCC through higher affinity for FC gamma RIII.
    Davies J; Jiang L; Pan LZ; LaBarre MJ; Anderson D; Reff M
    Biotechnol Bioeng; 2001 Aug; 74(4):288-94. PubMed ID: 11410853
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular and cellular basis for pathogenicity of autoantibodies: lessons from murine monoclonal autoantibodies.
    Baudino L; Azeredo da Silveira S; Nakata M; Izui S
    Springer Semin Immunopathol; 2006 Oct; 28(2):175-84. PubMed ID: 16953439
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Distinctive role of IgG1 and IgG3 isotypes in Fc gamma R-mediated functions.
    Rozsnyay Z; Sármay G; Walker M; Maslanka K; Valasek Z; Jefferis R; Gergely J
    Immunology; 1989 Apr; 66(4):491-8. PubMed ID: 2523858
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ADCC (K-cell) lysis of human erythrocytes sensitized with rhesus alloantibodies. III. Comparison of IgG anti-D agglutinating and lytic (ADCC) activity and the role of IgG subclasses.
    Urbaniak SJ; Greiss MA
    Br J Haematol; 1980 Nov; 46(3):447-53. PubMed ID: 6778497
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Agalactosyl IgG and antibody specificity in rheumatoid arthritis, tuberculosis, systemic lupus erythematosus and myasthenia gravis.
    Pilkington C; Yeung E; Isenberg D; Lefvert AK; Rook GA
    Autoimmunity; 1995; 22(2):107-11. PubMed ID: 8722580
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Skewed Fc glycosylation profiles of anti-proteinase 3 immunoglobulin G1 autoantibodies from granulomatosis with polyangiitis patients show low levels of bisection, galactosylation, and sialylation.
    Wuhrer M; Stavenhagen K; Koeleman CA; Selman MH; Harper L; Jacobs BC; Savage CO; Jefferis R; Deelder AM; Morgan M
    J Proteome Res; 2015 Apr; 14(4):1657-65. PubMed ID: 25761865
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-agalactosyl IgG antibodies and isotype profiles of rheumatoid factors in Sjögren's syndrome and rheumatoid arthritis.
    Ichikawa Y; Yamada C; Horiki T; Hoshina Y; Uchiyama M; Yamada Y; Toumatu J
    Clin Exp Rheumatol; 1998; 16(6):709-15. PubMed ID: 9844764
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Functional activity of human Rh monoclonal antibodies (MABS).
    Kumpel BM
    J Immunogenet; 1990; 17(4-5):321-30. PubMed ID: 2128776
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Affinity of the interaction between Fc gamma receptor type III (Fc gammaRIII) and monomeric human IgG subclasses. Role of Fc gammaRIII glycosylation.
    Galon J; Robertson MW; Galinha A; Mazières N; Spagnoli R; Fridman WH; Sautès C
    Eur J Immunol; 1997 Aug; 27(8):1928-32. PubMed ID: 9295028
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nonhemolytic red cell autoantibodies consist of multiple immunoglobulin G populations directed against complex membrane epitopes.
    Masouredis SP; Branks MJ; Pierce SW; Victoria EJ
    J Lab Clin Med; 1989 May; 113(5):569-76. PubMed ID: 2469755
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The N-terminal end of the CH2 domain of chimeric human IgG1 anti-HLA-DR is necessary for C1q, Fc gamma RI and Fc gamma RIII binding.
    Morgan A; Jones ND; Nesbitt AM; Chaplin L; Bodmer MW; Emtage JS
    Immunology; 1995 Oct; 86(2):319-24. PubMed ID: 7490135
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Autoreactive sites of human lambda light chain mapped by comprehensive peptide synthesis.
    Kaymaz H; Marchalonis JJ
    J Protein Chem; 1993 Dec; 12(6):659-66. PubMed ID: 8136016
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Soluble Fc gamma RIII (CD16) and immunoglobulin G levels in seminal plasma of men with immunological infertility.
    Sedor J; Callahan HJ; Perussia B; Lattime EC; Hirsch IH
    J Androl; 1993; 14(3):187-93. PubMed ID: 8407574
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Variations in oligosaccharide-protein interactions in immunoglobulin G determine the site-specific glycosylation profiles and modulate the dynamic motion of the Fc oligosaccharides.
    Wormald MR; Rudd PM; Harvey DJ; Chang SC; Scragg IG; Dwek RA
    Biochemistry; 1997 Feb; 36(6):1370-80. PubMed ID: 9063885
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.